Table 4.
Laboratory Data of the Four Studied Groups
| Parameter | HCC (n=40) | Cirrhosis (n=20) | HCV (n=20) | Control (n=40) | p |
|---|---|---|---|---|---|
| PC (%) | 71.75 (59-80) |
53* (37-72) |
99.5*† (96-100) |
97.5*† (93.25-100) |
<0.001 |
| INR | 1.31 (1.2-1.5) |
1.5 (1.3-1.97) |
1.005*† (1.0-1.09) |
1.03*† (1-1.09) |
<0.001 |
| ALT (IU/l) | 55 (46-79.5) |
46 (18.5-95) |
28.5*† (15-45.5) |
10*†‡ (10-16.75) |
<0.001 |
| AST (IU/l) | 64.5 (46.5-93) |
59.5 (33-116) |
27.5*† (20.25-38.75) |
16.5*†‡ (12.25-26) |
<0.001 |
| Albumin (g/dl) | 2.82 (2.52-3.0) |
2.75 (2.42-3.0) |
4.2*† (3.9-4.5) |
4.1*† (3.9-4.3) |
<0.001 |
| TBIL (mg/dl) | 2.0 (1.0-3.9) |
2.1 (1.05-6.02) |
0.5*† (0.37-0.6) |
0.75*† (0.5-0.9) |
<0.001 |
| DBIL (mg/dl) | 0.61 (0.32-2.27) |
0.7 (0.27-3.57) |
0.115*† (0.1-0.2) |
0.1*†‡ (0-0.1) |
<0.001 |
| AFP(ng/ml) | 271 (141.75-506.25) |
15.5 (9.1-63.25) * |
4 (3 - 5.6) *† |
---- | <0.001 |
Data are presented median (25th -75th percentiles); *significant difference from the HCC group; † significant difference from the liver cirrhosis group, ‡ significant difference from HCV group